Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-06

Clinical Trial Update: Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating melatonin for diabetic peripheral neuropathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Ain Shams University | Conditions: Diabetic Peripheral Neuropathy, Diabetic Neuropathy | Phase 2 | Status: RECRUITING